Have thought about this as well but I'm not sure it matters. In real world situations patients will be treated daily to remove the risk of MRSA while in hospital (and perhaps asked to continue self treatment while they recover at home). I don't think the goal is to eradicate staff completely and forever. Just long enough so the patient doesn't infect themselves. I think the more critical assessment will be proof that MRSA does not develop resistance over longer periods of time. This is the true value of the drug
Ann: Results of Meeting, page-17
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $642.5M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 36.0¢ | 34.5¢ | $1.358M | 3.872M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1354176 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 82352 | 4 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |